Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...